601 related articles for article (PubMed ID: 26216710)
1. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
2. The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.
Fang L; Lowther DE; Meizlish ML; Anderson RC; Bruce JN; Devine L; Huttner AJ; Kleinstein SH; Lee JY; Stern JN; Yaari G; Lovato L; Cronk KM; O'Connor KC
Neuro Oncol; 2013 Nov; 15(11):1479-90. PubMed ID: 23978377
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
Stevens A; Klöter I; Roggendorf W
Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
[TBL] [Abstract][Full Text] [Related]
5. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
[TBL] [Abstract][Full Text] [Related]
6. Association between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomas.
Domingues PH; Teodósio C; Otero Á; Sousa P; Ortiz J; Macias Mdel C; Gonçalves JM; Nieto AB; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
PLoS One; 2013; 8(10):e74798. PubMed ID: 24098347
[TBL] [Abstract][Full Text] [Related]
7. Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.
Zadka L; Kram P; Koscinski J; Jankowski R; Kaczmarek M; Piatek K; Kulus M; Gomułkiewicz A; Piotrowska A; Dziegiel P
Anticancer Res; 2017 Oct; 37(10):5777-5783. PubMed ID: 28982901
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
[TBL] [Abstract][Full Text] [Related]
9. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma.
Du Z; Abedalthagafi M; Aizer AA; McHenry AR; Sun HH; Bray MA; Viramontes O; Machaidze R; Brastianos PK; Reardon DA; Dunn IF; Freeman GJ; Ligon KL; Carpenter AE; Alexander BM; Agar NY; Rodig SJ; Bradshaw EM; Santagata S
Oncotarget; 2015 Mar; 6(7):4704-16. PubMed ID: 25609200
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of survival following depletion of CD4+CD25+ regulatory T cells in mice with experimental brain tumors.
El Andaloussi A; Han Y; Lesniak MS
J Neurosurg; 2006 Sep; 105(3):430-7. PubMed ID: 16961139
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical study of the cellular immune response in meningiomas.
Rossi ML; Cruz Sanchez F; Hughes JT; Esiri MM; Coakham HB
J Clin Pathol; 1988 Mar; 41(3):314-9. PubMed ID: 3258871
[TBL] [Abstract][Full Text] [Related]
13. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors.
Morantz RA; Wood GW; Foster M; Clark M; Gollahon K
J Neurosurg; 1979 Mar; 50(3):305-11. PubMed ID: 422981
[TBL] [Abstract][Full Text] [Related]
14. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
15. Characterization of immune cell infiltration into canine intracranial meningiomas.
Boozer LB; Davis TW; Borst LB; Zseltvay KM; Olby NJ; Mariani CL
Vet Pathol; 2012 Sep; 49(5):784-95. PubMed ID: 21987303
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of central and peripheral immunomodulation in a murine glioma model.
Kennedy BC; Maier LM; D'Amico R; Mandigo CE; Fontana EJ; Waziri A; Assanah MC; Canoll P; Anderson RC; Anderson DE; Bruce JN
BMC Immunol; 2009 Feb; 10():11. PubMed ID: 19226468
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
18. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
19. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas.
Badie B; Schartner JM
Neurosurgery; 2000 Apr; 46(4):957-61; discussion 961-2. PubMed ID: 10764271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
